Financials ANGLE plc

Equities

AGL

GB0034330679

Advanced Medical Equipment & Technology

Market Closed - London S.E. 11:35:12 2024-04-26 am EDT 5-day change 1st Jan Change
14.5 GBX +3.57% Intraday chart for ANGLE plc +20.83% +23.40%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 55.92 108.3 102.8 279.7 131.5 37.77 37.77 -
Enterprise Value (EV) 1 48.27 97.25 74.18 247.8 99.64 25.2 36.16 37.77
P/E ratio -3.87 x -9.56 x -7.32 x -17.8 x -5.75 x -1.92 x -2.56 x -2.76 x
Yield - - - - - - - -
Capitalization / Revenue 89 x 160 x 135 x 276 x 126 x 18.2 x 4.96 x 2.2 x
EV / Revenue 76.9 x 143 x 97.4 x 245 x 95.7 x 12.1 x 4.75 x 2.2 x
EV / EBITDA -6.17 x -10.2 x -6.03 x -15.7 x -4.66 x -1.35 x -2.59 x -3.02 x
EV / FCF -5,565,614 x -11,221,637 x -8,880,044 x -15,688,470 x - - - -
FCF Yield -0% -0% -0% -0% - - - -
Price to Book 2.87 x 4.65 x 2.99 x 6.93 x - 1.81 x 3.63 x 2.9 x
Nbr of stocks (in thousands) 143,373 172,658 215,292 235,030 260,467 260,467 260,467 -
Reference price 2 0.3900 0.6270 0.4775 1.190 0.5050 0.1450 0.1450 0.1450
Announcement Date 7/25/18 7/31/19 4/29/21 4/28/22 4/21/23 - - -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 0.628 0.678 0.762 1.013 1.041 2.08 7.615 17.15
EBITDA 1 -7.819 -9.493 -12.31 -15.75 -21.37 -18.65 -13.98 -12.5
EBIT 1 -8.933 -10.9 -13.73 -17.24 -24.21 -20.65 -16.08 -14.4
Operating Margin -1,422.45% -1,607.52% -1,801.97% -1,701.38% -2,325.36% -992.74% -211.15% -83.97%
Earnings before Tax (EBT) 1 -8.925 -10.87 -13.74 -17.36 -24.44 -21.2 -17.37 -19.3
Net income 1 -7.556 -8.942 -11.61 -15.01 -21.69 -19.44 -14.91 -13.85
Net margin -1,203.18% -1,318.88% -1,523.1% -1,481.93% -2,083.19% -934.29% -195.86% -80.76%
EPS 2 -0.1009 -0.0656 -0.0652 -0.0667 -0.0879 -0.0753 -0.0567 -0.0525
Free Cash Flow -8.673 -8.666 -8.354 -15.8 - - - -
FCF margin -1,381.05% -1,278.17% -1,096.33% -1,559.53% - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 7/25/18 7/31/19 4/29/21 4/28/22 4/21/23 - - -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2
Net sales 1 - 0.717 0.419 0.622 - 1.8
EBITDA - - - - - -
EBIT 1 - -8.573 -10.37 -13.84 - -11.5
Operating Margin - -1,195.68% -2,473.99% -2,225.24% - -638.89%
Earnings before Tax (EBT) 1 - -8.644 -10.5 -13.94 - -11.8
Net income 1 -7.683 -7.329 -9.221 -12.46 -9.813 -10.3
Net margin - -1,022.18% -2,200.72% -2,004.02% - -572.22%
EPS 2 -0.0357 -0.0310 -0.0392 -0.0487 -0.0377 -0.0390
Dividend per Share - - - - - -
Announcement Date 9/30/21 4/28/22 9/29/22 4/21/23 9/7/23 -
1GBP in Million2GBP
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 - - - - - - - -
Net Cash position 1 7.65 11 28.6 31.8 31.9 12.6 1.6 -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow -8.67 -8.67 -8.35 -15.8 - - - -
ROE (net income / shareholders' equity) -58% -49.9% -38.1% -40.2% - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 0.1400 0.1300 0.1600 0.1700 - 0.0800 0.0400 0.0500
Cash Flow per Share 2 - - - -0.0600 -0.0700 -0.0600 -0.0400 -0.0400
Capex 1 1.86 1.35 0.51 1.79 1.89 0.95 1.21 1.95
Capex / Sales 296.34% 199.41% 66.4% 176.51% 181.27% 45.76% 15.95% 11.37%
Announcement Date 7/25/18 7/31/19 4/29/21 4/28/22 4/21/23 - - -
1GBP in Million2GBP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.145 GBP
Average target price
0.685 GBP
Spread / Average Target
+372.41%
Consensus